SLSN
Solesence, Inc. Common Stock
SLSN's fundamentals are strong and it looks cheap: trading at 15x earnings, less than half its usual 67x.
SLSN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
SLSN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
SLSN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 15x | $0.91 | — |
| Cheap | 45x | $2.73 | +200% |
| Fair | 66x | $3.97 | +337% |
| Expensive | 130x | $7.78 | +755% |
Historical ranges are pointers, not guarantees.
SLSN's PE is in its cheap range at 15x.
SLSN Forward outlook
There aren't enough analyst estimates for SLSN to show an outlook.
SLSN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.06 | +$0.08 |
| Q2 2026 | $0.00 | -100% |
| Q1 2026 | $0.04 | +$0.04 |
| Q4 2025 | $0.05 | +150% |
| Q3 2025 | -$0.02 | -200% |
| Q2 2025 | $0.03 | +$0.08 |
| Q1 2025 | $0.00 | +$0.05 |
| Q4 2024 | $0.02 | +$0.11 |
SLSN has returned to profit: it earned $0.06 per share over the past year, after losing money the year before.
SLSN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.2M | +38% |
| Q2 2026 | $15.3M | -25% |
| Q1 2026 | $13M | -11% |
| Q4 2025 | $12.5M | -0.7% |
| Q3 2025 | $14.6M | -13% |
| Q2 2025 | $20.4M | +56% |
| Q1 2025 | $14.6M | +48% |
| Q4 2024 | $12.6M | +57% |
SLSN's revenue has held roughly level: $20M last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +25 points |
| Q2 2026 | 0.1% | -9.2 points |
| Q1 2026 | -5.2% | -7 points |
| Q4 2025 | 9.7% | +36 points |
| Q3 2025 | -4.6% | -24 points |
| Q2 2025 | 9.4% | +1.4 points |
| Q1 2025 | 1.8% | -9.5 points |
| Q4 2024 | -27% | -3.1 points |
SLSN's operating margin was 20% last quarter, up 25 points from the same quarter a year ago, near the top of its range since 2019.
SLSN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.7M | +$9.2M |
| Q2 2026 | $191K | +$845K |
| Q1 2026 | $1.5M | +$8.7M |
| Q4 2025 | $1.8M | +$2.2M |
| Q3 2025 | -$2.5M | -190% |
| Q2 2025 | -$654K | +$388K |
| Q1 2025 | -$7.2M | -$3.3M |
| Q4 2024 | -$404K | +$2.4M |
SLSN's free cash flow has turned positive after six years mostly in the red: $10M over the past year.
SLSN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 3.6x | Elevated |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 2.2x | Moderate |
| Q2 2022 | -0.4x | Net Cash |
| Q1 2022 | -0.3x | Net Cash |
SLSN's net debt is less than a year of its operating earnings (EBITDA), down from 3.9 years a year ago.
SLSN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.9 | Neutral |
| Stochastic | 26.1 | Neutral |
SLSN's weekly RSI is 46 (neutral) and its Stochastic is 26 (neutral).
SLSN PE vs Consumer Defensive Sector
| Metric | SLSN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 19x | 22% below |
| PE % | 0 | 18 | 18 pts below |
SLSN is trading at 15x earnings, a 22% discount to the Consumer Defensive sector's median of 19x.
SLSN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.87 | 4.6% above |
| 20 week MA | $0.87 | 4.6% above |
| 50 week MA | $1.16 | 22% below |
| 100 week MA | $2.15 | 58% below |
| 200 week MA | $1.69 | 46% below |
SLSN has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 46% below its 200-week average.
SLSN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.27 | $0.80 | +196% |
| 2021 | $0.80 | $4.24 | +430% |
| 2022 | $4.24 | $1.18 | -72% |
| 2023 | $1.18 | $0.60 | -49% |
| 2024 | $0.60 | $2.30 | +283% |
| 2025 | $2.30 | $1.81 | -21% |
| 2026 YTD | $1.81 | $0.91 | -50% |
SLSN's yearly returns have swung widely, from +430% in 2021 to −72% in 2022. It's down 50% so far in 2026.